FGFR1, a fibroblast growth factor receptor, has been reported to fuse with BCR in other B-ALL cases, causing expression of a dominant fusion protein resistant to tyrosine kinase inhibitors, but its fusion with AUTS2 remains uncharacterized [39,40]. This evidence concerns the gene BCR and precursor B-cell acute lymphoblastic leukemia.